Skip to main content

Thousand Oaks Inspire Therapy Sleep Apnea Device: Mask-Free Treatment Updated

Southern California Pulmonary and Sleep Disorders Medical Center (805-557-9930) announced updates to its FDA-approved Inspire Therapy services - an alternative to CPAP for obstructive sleep apnea (OSA) patients.

The new Inspire upper airway stimulation device from Southern California Pulmonary and Sleep Disorders Medical Center is a minimally invasive alternative to CPAP - a treatment that some OSA patients cannot tolerate due to physical discomfort, noise disturbance, pressure intolerance, or allergies.

More details can be found at https://sleepmd4u.com/

Working from within the body, the Inspire implant synchronizes with the patient’s natural breathing process and keeps the airway open without unpleasant side effects. According to a European Respiratory Society study, 96% of patients say they prefer it to CPAP and 93% would recommend it to family and friends.

At the center, led by board-certified sleep medicine specialist Dr. Ronald Popper, patients undergo minor surgery during which a small Inspire impulse generator is implanted just below their clavicle. A breathing-sensing lead is placed between the ribs and a stimulation lead is attached to the hypoglossal nerve that controls movement of the tongue and airway muscles. When the device detects airway closure, it sends mild stimulation to move these muscles and open the breathing passages, allowing for uninterrupted breathing.

Controlled by a handheld remote, the Inspire device can be turned on before bed and off after waking. Its stimulation strength can be adjusted, and patients can pause the therapy if needed without getting out of bed.

Southern California Pulmonary and Sleep Disorders Medical Center has reported high patient satisfaction with Inspire Therapy, particularly among long-term OSA sufferers who have not found success with traditional masks and other oral appliances and procedures.

Potential patients can contact the clinic to book a consultation with Dr. Ronald Popper, MD, FCCP, FAASM, DABSM. This will involve an overall health evaluation and physical examination of the airway to determine their suitability for Inspire treatment.

Alongside Inspire Therapy, Southern California Pulmonary and Sleep Disorders Medical Center offers the BongoRX nasal EPAP device and eXciteOSA daytime treatment for mild to moderate OSA and snoring. Other conditions treated by the clinic include restless limb syndrome, insomnia, narcolepsy, excessive daytime sleepiness, and fatigue.

“Are you concerned that the dreaded CPAP mask is the only treatment for OSA? Have you already tried CPAP and didn’t tolerate it, or just don’t even want to try it?" asks a spokesperson for the company. “Well, don’t worry. We offer a variety of treatment alternatives to CPAP like Inspire Therapy to help eligible patients take control of their sleep apnea and give them the restful night’s sleep they’ve been missing.”

Interested parties can find out more about Inspire Therapy at Southern California Pulmonary and Sleep Disorders Medical Center by visiting https://sleepmd4u.com/

Contact Info:
Name: Ronald A. Popper, MD, FCCP, FAASM, DABSM
Email: Send Email
Organization: Southern California Pulmonary and Sleep Disorders Medical Center
Address: 317 S. Moorpark Road, Thousand Oaks, CA 91361, United States
Phone: +1-805-557-9930
Website: https://sleepmd4u.com

Source: PressCable

Release ID: 89140027

If you come across any problems, discrepancies, or concerns related to the content contained within this press release that necessitate action or if a press release requires takedown, we strongly encourage you to reach out without delay by contacting error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our committed team will be readily accessible round-the-clock to address your concerns within 8 hours and take appropriate actions to rectify identified issues or support with press release removals. Ensuring accurate and reliable information remains our unwavering commitment.

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.